Metabolic associated fatty liver disease (MAFLD) is a global health problem associated with extrahepatic manifestations and comorbidities. The main cause of mortality for those with MAFLD is cardiovascular diseases (CVD). Objective: The aim of this study was to evaluate silent cardiac dysfunction in MAFLD patients. Material and Methods: This study was carried out on 1500 subjects from Beni-Suef population. All patients subjected to pelvi–abdominal ultra-sound as a screening tool, transient elastography to determine degree of steatosis/fibrosis, speckle tracking echocardiography and calculation of ASCVD (atherosclerotic cardiovascular disease risk score). Results: Our findings demonstrated a substantial correlation between MAFLD and higher E/e`, LA diameter, diastolic dysfunction grade II. There was a significant positive linear correlation between the Elastography with global longitudinal strain. The study showed a significant difference between non MAFLD, lean MAFLD and obese MAFLD regarding Atherosclerotic Cardiovascular Disease risk score (ASCVD). Conclusion: There was higher prevalence of subclinical cardiac dysfunction in MAFLD patients. So MAFLD patients should be evaluated for CVD and referred to a cardiologist, if needed.